BBB

BANGKOK GENOMICS INNOVATION PUBLIC NON-VOTING

No trades
See on Supercharts
Market capitalization
‪32.14 M‬THB
‪245.39 M‬THB
‪154.36 M‬
Beta (1Y)
2.95

About BANGKOK GENOMICS INNOVATION PUBLIC


CEO
Saowalak Dansakul
Headquarters
Bangkok
Founded
2017
ISIN
THB972010R10
FIGI
BBG01M2M58Y9
Bangkok Genomics Innovation PCL engages in the provision of screening services for fetal chromosomal abnormalities. It offers screening for genetic abnormalities, analysis infectious disease group, cancer related screening, genetic code analysis with whole exome sequencing, individual genetic testing, newborn screening, basic health check-up, providing technology services and other medical products. The company was founded in 2017 and is headquartered in Bangkok, Thailand.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.